HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes

Molecular Cancer Research

Volumn 8, Issue 12, 2010, Pages 1643-1655

  Axlund, Sunshine Daddario ^a,b   Lambert, James R ^a   Nordeen, Steven K ^a,b  

^a Department of Pathology ^*  (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BETA ACTIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE; HOMEODOMAIN PROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN HOXC8; STEROID RECEPTOR COACTIVATOR 3; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL STRAIN LNCAP; ENHANCER REGION; GENE CLUSTER; GENE INDUCTION; GENE TARGETING; HOMEOBOX; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ACETYLATION; ANDROGENS; CELL LINE, TUMOR; CELL MOVEMENT; CREB-BINDING PROTEIN; ENHANCER ELEMENTS, GENETIC; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HOMEODOMAIN PROTEINS; HUMANS; MALE; NEOPLASM INVASIVENESS; NUCLEAR RECEPTOR COACTIVATOR 3; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 78650440810     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0111     Document Type: Article

References (83)

1. Miller GJ, Miller HL, van BA, Lambert JR, Werahera PN, Schirripa O, et al. Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Cancer Res 2003;63(18):5879-88.
2. Lewis EB. A gene complex controlling segmentation in Drosophila. Nature 1978;276(5688):565-70.
3. Pearson JC, Lemons D, McGinnis W. Modulating Hox gene functions during animal body patterning. Nat Rev Genet 2005;6(12):893-904.
4. Mann RS, Morata G. The developmental and molecular biology of genes that subdivide the body of Drosophila. Annu Rev Cell Dev Biol 2000;16:243-71.
5. McGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell 1992;68(2):283-302.
6. Lawrence HJ, Stage KM, Mathews CH, Detmer K, Scibienski R, MacKenzie M, et al. Expression of HOX C homeobox genes in lymphoid cells. Cell Growth Differ 1993;4(8):665-9.
7. Celetti A, Barba P, Cillo C, Rotoli B, Boncinelli E, Magli MC. Characteristic patterns of HOX gene expression in different types of human leukemia. Int J Cancer 1993;53(2):237-44.
8. Perkins A, Kongsuwan K, Visvader J, Adams JM, Cory S. Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. Proc Natl Acad Sci USA 1990;87(21): 8398-402.
9. Lawrence HJ, Sauvageau G, Ahmadi N, Lopez AR, LeBeau MM, Link M, et al. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells. Exp Hematol 1995;23(11):1160-6.
10. Borrow J, Shearman AM, Stanton VP Jr, Becher R, Collins T, Williams AJ, et al. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet 1996;12(2):159-67.
11. Frohling S, Scholl C, Bansal D, Huntly BJ. HOX gene regulation in acute myeloid leukemia: CDX marks the spot? Cell Cycle 2007;6 (18):2241-45.
12. Shimamoto T, Ohyashiki K, Toyama K, Takeshita K. Homeobox genes in hematopoiesis and leukemogenesis. Int J Hematol 1998;67(4):339-50.
13. Alami Y, Castronovo V, Belotti D, Flagiello D, Clausse N. HOXC5 and HOXC8 expression are selectively turned on in human cervical cancer cells compared to normal keratinocytes. Biochem Biophys Res Commun 1999;257(3):738-45.
14. De VG, Barba P, Odartchenko N, Givel JC, Freschi G, Bucciarelli G, et al. Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur J Cancer 1993;29A(6):887-93.
15. Chariot A, Castronovo V. Detection of HOXA1 expression in human breast cancer. Biochem Biophys Res Commun 1996;222(2):292-7.
16. Chariot A, Castronovo V, Le P, Gillet C, Sobel ME, Gielen J. Cloning and expression of a new HOXC6 transcript encoding a repressing protein. Biochem J 1996;319(Pt 1):91-7.
17. Buccoliero AM, Castiglione F, Degl'Innocenti DR, Ammanati F, Giordano F, Sanzo M, et al. Hox-D genes expression in pediatric lowgrade gliomas: Real-time-PCR study. Cell Mol Neurobiol 2009;29(1): 1-6.
18. Cillo C, Barba P, Freschi G, Bucciarelli G, Magli MC, Boncinelli E. HOX gene expression in normal and neoplastic human kidney. Int J Cancer 1992;51(6):892-7.
19. Abe M, Hamada J, Takahashi O, Takahashi Y, Tada M, Miyamoto M, et al. Disordered expression of HOX genes in human non-small cell lung cancer. Oncol Rep 2006;15(4):797-802.
20. Lechner JF, Wang Y, Siddiq F, Fugaro JM, Wali A, Lonardo F, et al. Human lung cancer cells and tissues partially recapitulate the homeobox gene expression profile of embryonic lung. Lung Cancer 2002;37 (1):41-7.
21. Gu ZD, Chen XM, Zhang W, Gu J, Chen KN. [Expression of 39 HOX genes in esophageal cancer cell lines]. Zhonghua Wei Chang Wai Ke Za Zhi 2007;10(4):365-7.
22. Waltregny D, Alami Y, Clausse N, de LJ, Castronovo V. Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate 2002;50 (3):162-9.
23. Kikugawa T, Kinugasa Y, Shiraishi K, Nanba D, Nakashiro K, Tanji N, et al. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation. Prostate 2006;66(10):1092-9.
24. Ramachandran S, Liu P, Young AN, Yin-Goen Q, Lim SD, Laycock N, et al. Loss of HOXC6 expression induces apoptosis in prostate cancer cells. Oncogene 2005;24(1):188-98.
25. Shen WF, Krishnan K, Lawrence HJ, Largman C. The HOX homeodomain proteins block CBP histone acetyltransferase activity. Mol Cell Biol 2001;21(21):7509-2.
26. Norris JD, Chang CY, Wittmann BM, Kunder RS, Cui H, Fan D, et al. The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol Cell 2009;36(3):405-16.
27. Jung C, Kim RS, Zhang HJ, Lee SJ, Jeng MH. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone- activated androgen receptor signaling. Cancer Res 2004;64 (24):9185-92.
28. Zhou HJ, Yan J, Luo W, Ayala G, Lin SH, Erdem H, et al. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res 2005;65(17):7976-83.
29. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997;277(5328):965-8.
30. Balmer NN, Richer JK, Spoelstra NS, Torkko KC, Lyle PL, Singh M. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers. Mod Pathol 2006;19(12):1593-605.
31. Tanner MM, Grenman S, Koul A, Johannsson O, Meltzer P, Pejovic T, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000;6(5):1833-9.
32. Henke RT, Haddad BR, Kim SE, Rone JD, Mani A, Jessup JM, et al. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Clin Cancer Res 2004;10(18 Pt 1):6134-42.
33. Ghadimi BM, Schrock E, Walker RL, Wangsa D, Jauho A, Meltzer PS, et al. Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am J Pathol 1999;154(2):525-36.
34. Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, NakanishiM, Masuda K, et al. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer 2000;89 (3):217-23.
35. Xie D, Sham JS, Zeng WF, Lin HL, Bi J, Che LH, et al. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma. Hum Pathol 2005;36(7):777-83.
36. Wang Y, Wu MC, Sham JS, Zhang W, Wu WQ, Guan XY. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer 2002;95(11):2346-52.
37. Nessler-Menardi C, Jotova I, Culig Z, Eder IE, Putz T, Bartsch G, et al. Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture models. Prostate 2000; 45(2):124-31.
38. Gnanapragasam VJ, Leung HY, Pulimood AS, Neal DE, Robson CN. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer. Br J Cancer 2001;85(12):1928-36.
39. Zou JX, Zhong Z, Shi XB, Tepper CG, deVere White RW, Kung HJ, et al. ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes. Prostate 2006;66(14):1474-86.
40. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, et al. The LNCaP cell line-a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 1980;37:115-32.
41. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, et al. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43(4):1809-18.
42. Ling MT, Chan KW, Choo CK. Androgen induces differentiation of a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line. J Endocrinol 2001;170(1):287-96.
43. Lambert JR, Kelly JA, Shim M, Huffer WE, Nordeen SK, Baek SJ, et al. Prostate derived factor in human prostate cancer cells: Gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth. J Cell Physiol 2006;208(3):566-74.
44. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Methods. Methods 2001;25(4):402-8.
45. Perez-Stable CM, Pozas A, Roos BA. A role for GATA transcription factors in the androgen regulation of the prostate-specific antigen gene enhancer. Mol Cell Endocrinol 2000;167(1-2):43-53.
46. Lambert JR, Nordeen SK. CBP recruitment and histone acetylation in differential gene induction by glucocorticoids and progestins. Mol Endocrinol 2003;17(6):1085-94.
47. Detection of protein-protein interactions using the GST fusion protein pull-down technique. Nat Methods 2004;1(3):275-6.
48. Louie MC, Yang HQ, Ma AH, Xu W, Zou JX, Kung HJ, et al. Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc Natl Acad Sci USA 2003; 100(5):2226-30.
49. Jia L, Coetzee GA. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus. Cancer Res 2005;65(17): 8003-8.
50. Jia L, Kim J, Shen H, Clark PE, Tilley WD, Coetzee GA. Androgen receptor activity at the prostate specific antigen locus: Steroidal and non-steroidal mechanisms. Mol Cancer Res 2003;1(5):385-92.
51. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/ p300. Cell 1997;90(3):569-80.
52. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, et al. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 1997;387(6634):677-84.
53. Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, et al. Regulation of transcription by a protein methyltransferase. Science 1999;284(5423):2174-7.
54. McKenna NJ, O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002;108(4):465-74.
55. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996;85(3):403-14.
56. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, et al. Role of CBP/P300 in nuclear receptor signalling. Nature 1996;383(6595):99-103.
57. Kamel S, Kruger C, Salbaum JM, Kappen C. Morpholino-mediated knockdown in primary chondrocytes implicates Hoxc8 in regulation of cell cycle progression. Bone 2009;44(4):708-16.
58. Lei H, Juan AH, Kim MS, Ruddle FH. Identification of a Hoxc8- regulated transcriptional network in mouse embryo fibroblast cells. Proc Natl Acad Sci U S A 2006;103(27):10305-9.
59. Min H, Lee JY, Bok J, Chung HJ, Kim MH. Proliferating cell nuclear antigen (Pcna) as a direct downstream target gene of Hoxc8. Biochem Biophys Res Commun 2010;392(4):543-7.
60. Kwon Y, Ko JH, Byung-Gyu K, Kim MH. Analysis of plausible downstream target genes of Hoxc8 in F9 teratocarcinoma cells. Putative downstream target genes of Hoxc8. Mol Biol Rep 2003;30(3):141-8.
61. Lei H, Wang H, Juan AH, Ruddle FH. The identification of Hoxc8 target genes. Proc Natl Acad Sci USA 2005;102(7):2420-4.
62. Juan AH, Lei H, Bhargava P, Lebrun M, Ruddle FH. Multiple roles of hoxc8 in skeletal development. Ann N Y Acad Sci 2006;1068:87-94.
63. Yueh YG, Gardner DP, Kappen C. Evidence for regulation of cartilage differentiation by the homeobox gene Hoxc-8. Proc Natl Acad Sci USA 1998;95(17):9956-61.
64. Yang X, Ji X, Shi X, Cao X. Smad1 domains interacting with Hoxc-8 induce osteoblast differentiation. J Biol Chem 2000;275(2):1065-72.
65. Zheng YJ, Chung HJ, Min H, Kang M, Kim SH, Gadi J, et al. In vitro osteoblast differentiation is negatively regulated by Hoxc8. Appl Biochem Biotechnol 2010;160(3):891-900.
66. Magli MC, Largman C, Lawrence HJ. Effects of HOX homeobox genes in blood cell differentiation. J Cell Physiol 1997;173(2):168-77.
67. Shimamoto T, Tang Y, Naot Y, Nardi M, Brulet P, Bieberich CJ, et al. Hematopoietic progenitor cell abnormalities in Hoxc-8 null mutant mice. J Exp Zool 1999;283(2):186-93.
68. Tomotsune D, Shoji H, Wakamatsu Y, Kondoh H, Takahashi N. A mouse homologue of the Drosophila tumour-suppressor gene l(2)gl controlled by Hox-C8 in vivo. Nature 1993;365(6441):69-72.
69. Lei H, Juan AH, Kim MS, Ruddle FH. Mouse naked cuticle 2 (mNkd2) as a direct transcriptional target of Hoxc8 in vivo. J Exp Zool A Ecol Genet Physiol 2007;307(1):1-6.
70. Feltes CM, Kudo A, Blaschuk O, Byers SW. An alternatively spliced cadherin-11 enhances human breast cancer cell invasion. Cancer Res 2002;62(22):6688-97.
71. Tuck AB, Hota C, Wilson SM, Chambers AF. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Oncogene 2003;22(8):1198-205.
72. Philip YW, Paul CK. The role of osteopontin in tumor metastasis. J Surg Res 2004;121(2):228-41.
73. Guan XY, Xu J, Anzick SL, Zhang H, Trent JM, Meltzer PS. Hybrid selection of transcribed sequences from microdissected DNA: Isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res 1996;56(15):3446-50.
74. Wu RC, Qin J, Yi P, Wong J, Tsai SY, Tsai MJ, et al. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic responses to multiple cellular signaling pathways. Mol Cell 2004;15 (6):937-49.
75. Zhou XE, Suino-Powell KM, Li J, He Y, Mackeigan JP, Melcher K, et al. Identification of SRC3/AIB1 as a preferred coactivator for hormoneactivated androgen receptor. J Biol Chem 2010;285(12): 9161-71.
76. Looijenga LH, Stoop H, de Leeuw HP, De Gouveia Brazao CA, Gillis AJ, Van Roozendaal KE, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003;63 (9):2244-50.
77. Gidekel S, Pizov G, Bergman Y, Pikarsky E. Oct-3/4 is a dosedependent oncogenic fate determinant. Cancer Cells 2003;4(5): 361-70.
78. Shen MM, Abate-Shen C. Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev Dyn 2003;228 (4):767-78.
79. Abate-Shen C. Homeobox genes and cancer: New OCTaves for an old tune. Cancer Cells 2003;4(5):329-30.
80. Gelmann EP, Henshall SM. Clinically relevant prognostic markers for prostate cancer: The search goes on. Ann Intern Med 2009;150 (9):647-9.
81. Scardino PT. Localized prostate cancer is rarely a fatal disease. Nat Clin Pract Urol 2008;5(1):1.
82. Swanson GP, Riggs M, Hermans M. Pathologic findings at radical prostatectomy: Risk factors for failure and death. Urol Oncol 2007;25 (2):110-4.
83. Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Longterm follow up of a randomized clinical trial. JUrol 2009;181(3):956-62.